NeuroPace, Inc. (NPCE)
14.72
-0.47
(-3.09%)
USD |
NASDAQ |
Sep 03, 16:00
14.72
0.00 (0.00%)
After-Hours: 20:00
NeuroPace Research and Development Expense (Annual) : 27.89M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 27.89M |
| December 31, 2024 | 23.65M |
| December 31, 2023 | 20.78M |
| December 31, 2022 | 21.95M |
| Date | Value |
|---|---|
| December 31, 2021 | 18.21M |
| December 31, 2020 | 15.70M |
| December 31, 2019 | 18.29M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Tandem Diabetes Care, Inc. | 174.84M |
| CVRx, Inc. | 11.13M |
| Accuray, Inc. | 37.75M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 65.85M |